Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 3 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 8 Pancreatic Neoplasms 7 Breast Neoplasms 7 Colorectal Neoplasms 6 Stomach Neoplasms 5 Neoplasms 5 Sarcoma 3 Precision Cell Immunotherapy 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Mesothelioma, Malignant 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hodgkin Disease 3 Glioblastoma 3 Esophageal Neoplasms 3 Wilms Tumor 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Mesothelioma 2 Melanoma 2 Lymphoma 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Ovarian Epithelial 2 Virus Diseases 1

Interventions

Temozolomide 23 Radiotherapy 15 Radiation 7 Bevacizumab 6 temsirolimus 5 Sirolimus 5 Radiotherapy, Conformal 5 Erlotinib Hydrochloride 5 Carmustine 5 Carboplatin 5 Radiotherapy, Intensity-Modulated 4 Everolimus 4 Vorinostat 3 Irinotecan 3 veliparib 2 tipifarnib 2 plerixafor 2 pembrolizumab 2 atezolizumab 2 Surgical Procedures, Operative 2 Sorafenib 2 Gefitinib 2 Fluorodeoxyglucose F18 2 Cilengitide 2 Chemotherapy, Adjuvant 2 vatalanib 1 vandetanib 1 terameprocol 1 tandutinib 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Gliosarcoma × Drug Therapy × Clear all

NCT04528680 2026-04-13

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡